PMID- 21700440
OWN - NLM
STAT- MEDLINE
DCOM- 20111114
LR  - 20151119
IS  - 1532-3064 (Electronic)
IS  - 0954-6111 (Linking)
VI  - 105
IP  - 9
DP  - 2011 Sep
TI  - Minimal (clinically) important differences for the Fatigue Assessment Scale in 
      sarcoidosis.
PG  - 1388-95
LID - 10.1016/j.rmed.2011.05.004 [doi]
AB  - OBJECTIVE: The usefulness of any questionnaire in clinical management and 
      research trials depends on its ability to indicate a likelihood of treatment 
      success during follow-up. The Minimal Clinically Important Difference (MCID) 
      reflects a clinically relevant change score. The aim of this study was to 
      estimate the MCID for the Fatigue Assessment Scale (FAS) in patients with 
      sarcoidosis. METHODS: Outpatients (n = 321) of the ild care team of the 
      Department of Respiratory Medicine of the Maastricht University Medical Centre, 
      The Netherlands, participated in this prospective follow-up study. Anchor-based 
      and distribution-based methods were used to estimate the MCID. Based on the 
      anchor Physical Quality of Life, a Receiver Operating Characteristic (ROC) was 
      obtained. The distribution-based methods consisted of the Effect Size and 
      Standard Error Measurement (SEM). RESULTS: The anchor-based MCID found with ROC 
      was 3.5. The distribution-based methods showed that the corresponding change 
      scores in the FAS for a small effect was 4.2. The SEM criterion was 3.6 points 
      change in the FAS. CONCLUSIONS: Based on the anchor-based and distribution-based 
      methods, the MCID is a 4-point difference on the FAS. This MCID can be used in 
      the follow-up of fatigue (FAS) in clinical trials and in the management of 
      individual sarcoidosis cases.
CI  - Copyright (c) 2011 Elsevier Ltd. All rights reserved.
FAU - de Kleijn, Willemien P E
AU  - de Kleijn WP
AD  - Center of Research on Psychology in Somatic Diseases (CoRPS), Department of 
      Medical Psychology, Tilburg University, Tilburg, The Netherlands.
FAU - De Vries, Jolanda
AU  - De Vries J
FAU - Wijnen, Petal A H M
AU  - Wijnen PA
FAU - Drent, Marjolein
AU  - Drent M
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20110623
PL  - England
TA  - Respir Med
JT  - Respiratory medicine
JID - 8908438
SB  - IM
MH  - Activities of Daily Living
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Disability Evaluation
MH  - Fatigue/*diagnosis/etiology/psychology
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Middle Aged
MH  - Netherlands
MH  - Prospective Studies
MH  - Quality of Life/*psychology
MH  - Sarcoidosis, Pulmonary/complications/*diagnosis/psychology
MH  - Severity of Illness Index
MH  - Surveys and Questionnaires/*standards
MH  - Treatment Outcome
EDAT- 2011/06/28 06:00
MHDA- 2011/11/15 06:00
CRDT- 2011/06/25 06:00
PHST- 2010/11/18 00:00 [received]
PHST- 2011/04/01 00:00 [revised]
PHST- 2011/05/06 00:00 [accepted]
PHST- 2011/06/25 06:00 [entrez]
PHST- 2011/06/28 06:00 [pubmed]
PHST- 2011/11/15 06:00 [medline]
AID - S0954-6111(11)00167-3 [pii]
AID - 10.1016/j.rmed.2011.05.004 [doi]
PST - ppublish
SO  - Respir Med. 2011 Sep;105(9):1388-95. doi: 10.1016/j.rmed.2011.05.004. Epub 2011 
      Jun 23.